A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 496.71
C 32.97
GOOG 607.59
BAC 8.11
RIMM 15.62

Recently Added

CPIC 1.16
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.75

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.16
NBTH 12.50
IDVC 0.35
3.09 -0.02 (-0.65%) OREX

Click Here to Receive Instant E-mail and RSS Alerts


Trade OREX now with

Stock Details

Last Trade:3.09 Change:-0.02 (-0.65%) Prev Close:3.11 Open: 3.08 Days Range:3.01 – 3.10 52 Week Range: 1.22 - 3.56 Volume:143781 P/E: N/A
EPS:-0.74





Recent Blog Posts

Blog Posts on 02/08/12 at 12:41pm
Analysis Of Monday's Noteworthy Institutional 5% Ownership Filings In Healthcare Sector
Blog Posts on 02/08/12 at 4:49am
3 Biotech Companies Down But Not Out
Blog Posts on 01/30/12 at 3:49pm
Best Performing Stocks Year To Date
Blog Posts on 01/29/12 at 4:34am
Arena Pharmaceuticals Has Over A 300% Upside Potential In 2012
Blog Posts on 12/28/11 at 11:45am
Analysis Of Institutional 5% Ownership Filings On Tuesday
Blog Posts on 12/23/11 at 3:24am
Analysis Of Institutional 5% Ownership Filings This Week
Blog Posts on 12/02/11 at 11:25am
Buy Bristol-Myers And Sanofi For Backdoor Access To Biotech Growth
Blog Posts on 10/19/11 at 3:09pm
6 Biotech Stocks Analysts Expect To Double
Blog Posts on 10/11/11 at 9:45am
Will These 4 Biotech Stocks Make You Rich?
Blog Posts on 10/07/11 at 9:36am
Emisphere: Crown Jewel In Oral B12
Blog Posts on 09/21/11 at 2:13pm
Orexigen; FDA Reverses Position And Gives New Life To Contrave
Blog Posts on 09/19/11 at 1:32am
Small Cap Biotech: Top Buy And Sell Ideas Based On Last Week's Big News, Price Movers
Blog Posts on 09/13/11 at 4:09pm
Buy The First Trust Biotech Index Fund To Spread Risk And Build Wealth
Blog Posts on 08/29/11 at 4:53pm
Human Genome Sciences: A Buy For High-Risk Takers
Blog Posts on 08/18/11 at 12:32pm
Salvage Operations in the Biopharma Wreckage
Blog Posts on 08/15/11 at 8:13am
When to Buy Biotechnology Stocks?
Blog Posts on 08/10/11 at 4:11pm
Arena Updates Investors on Its Handling of Carcinogenicty Issues Related to Lorcaserin
Blog Posts on 08/10/11 at 10:43am
Orexigen Revisited: Chances for Contrave Approval Seem Slim
Blog Posts on 07/12/11 at 3:33am
Top Buy and Sell Ideas Based on Healthcare Sector's Q2 Losers
Blog Posts on 06/19/11 at 1:30pm
8 Potential Biotech Acquisition Candidates
Blog Posts on 06/13/11 at 12:29pm
Nokia and Apple Demonstrate the Importance of Downside Protection
Blog Posts on 06/06/11 at 8:11am
Orexigen Receives Bad News From FDA About Contrave
Blog Posts on 06/01/11 at 11:55am
Wednesday Options Brief: NOK, DG, ESV & OREX
Blog Posts on 05/27/11 at 1:08pm
Arena, Orexigen and Vivus: An Update on Their Obesity Drugs
Blog Posts on 04/27/11 at 4:46am
7 Dirt Cheap Biotech Stocks With Huge Upside
Blog Posts on 04/11/11 at 1:06pm
Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
Blog Posts on 04/08/11 at 8:44am
8 Promising Biotech Buyout Targets if Their Products Can Deliver
Blog Posts on 04/05/11 at 7:58am
Momentum Ideas: 5 Small Cap Stocks Boosted by Short Covering
Blog Posts on 04/04/11 at 4:40pm
Closing Bell: Mixed Fanfare on Wall Street (AAPL, BRK-B, GE, LUV, SMH, MCD, OREX)
Blog Posts on 04/01/11 at 4:15pm
Most Heavily Shorted Stocks in the U.S.